MedPath

A clinical trial to study the effects of very minute quantity of wheat in the pediatric patients with celiac disease.

Phase 2
Completed
Conditions
Health Condition 1: null- Celiac Disease
Registration Number
CTRI/2009/091/000346
Lead Sponsor
Indian Council of Medical Research ICMR New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Screening I (Atleast one month before baseline):

The subjects recruited for the study were biopsy and serology-proven celiac disease patients who were 7 to 12 yrs of age (either sex), and compliant on gluten-free diet for atleast 1 year.

The confirmed CD patients who satisfy the following criteria were included:

a)7 to 12 yrs of age.

b)Either sex.

c)Confirmed CD patients on gluten-free diet for at least 1year - By following a standard GFD compliance protocol.

d)CD patients who gave consent and were able to follow-up for the microchallenge.

Screening II (At Baseline)

Those patients were recruited for microchallenge who were Anti-EMA negative, showed improvement in Histology (Marsh criteria) from:

Severe to either moderate or mild villus atrophy or normal

OR

Moderate to mild villus atrophy or normal

OR

Mild villus atrophy to normal

Exclusion Criteria

The following patients were excluded:

a)Poorly compliant on GFD.

b)Those having other autoimmune diseases.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
C : V (Crypt depth / Villus height) ratioTimepoint: At baseline and end of three months intervention
Secondary Outcome Measures
NameTimeMethod
IEL (Intraepithelial lymphocyte) count, Surface Epithelial Cell height, lamina propria infiltration, Serological, nutritional,clinical, biochemical parametersTimepoint: At baseline and at end of three months intervention.
© Copyright 2025. All Rights Reserved by MedPath